Innate Pharma S.A. disclosed its total shares outstanding and voting rights as of April 16, 2026, comprising 93,934,210 shares with 93,921,863 theoretical voting rights.
Key takeaways
Total shares outstanding: 93,934,210, including 93,921,863 ordinary shares, 4,766 Preferred Shares 2016, and 7,581 Preferred Shares 2017.
Total theoretical voting rights: 93,921,863, used for shareholding threshold calculations.
Total exercisable voting rights: 93,903,288, excluding treasury shares with suspended rights.
No voting rights attached to Preferred Shares 2016 and 2017.
Disclosure pursuant to French Code de Commerce and AMF regulations.